Annual Net Income
-$187.35 M
-$34.36 M-22.46%
December 31, 2024
Summary
- As of March 12, 2025, KROS annual net profit is -$187.35 million, with the most recent change of -$34.36 million (-22.46%) on December 31, 2024.
- During the last 3 years, KROS annual net income has fallen by -$128.61 million (-218.93%).
- KROS annual net income is now -13933.93% below its all-time high of -$1.33 million, reached on December 31, 2018.
Performance
KROS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$46.03 M
+$6.93 M+13.09%
December 31, 2024
Summary
- As of March 12, 2025, KROS quarterly net profit is -$46.03 million, with the most recent change of +$6.93 million (+13.09%) on December 31, 2024.
- Over the past year, KROS quarterly net income has stayed the same.
- KROS quarterly net income is now -1573.06% below its all-time high of -$2.75 million, reached on December 31, 2019.
Performance
KROS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$187.35 M
-$5.78 M-3.18%
December 31, 2024
Summary
- As of March 12, 2025, KROS TTM net profit is -$187.35 million, with the most recent change of -$5.78 million (-3.18%) on December 31, 2024.
- Over the past year, KROS TTM net income has stayed the same.
- KROS TTM net income is now -5786.05% below its all-time high of -$3.18 million, reached on March 31, 2019.
Performance
KROS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
KROS Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.5% | 0.0% | 0.0% |
| 3 y3 years | -218.9% | -563.2% | -218.9% |
| 5 y5 years | -1418.8% | -1573.1% | -1418.8% |
KROS Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -218.9% | at low | -563.2% | +13.1% | -218.9% | at low |
| 5 y | 5-year | -1418.8% | at low | -1573.1% | +13.1% | -1418.8% | at low |
| alltime | all time | <-9999.0% | at low | -1573.1% | +13.1% | -5786.1% | at low |
Keros Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$187.35 M(+22.5%) | -$46.03 M(-13.1%) | -$187.35 M(+3.2%) |
| Sep 2024 | - | -$52.96 M(+17.0%) | -$181.57 M(+8.0%) |
| Jun 2024 | - | -$45.26 M(+5.0%) | -$168.05 M(+4.8%) |
| Mar 2024 | - | -$43.11 M(+7.1%) | -$160.30 M(+4.8%) |
| Dec 2023 | -$152.99 M(+46.2%) | -$40.24 M(+2.0%) | -$152.99 M(+7.4%) |
| Sep 2023 | - | -$39.44 M(+5.2%) | -$142.47 M(+12.6%) |
| Jun 2023 | - | -$37.51 M(+4.8%) | -$126.54 M(+8.8%) |
| Mar 2023 | - | -$35.80 M(+20.5%) | -$116.30 M(+11.1%) |
| Dec 2022 | -$104.68 M(+78.2%) | -$29.72 M(+26.4%) | -$104.68 M(+27.8%) |
| Sep 2022 | - | -$23.51 M(-13.8%) | -$81.90 M(+4.1%) |
| Jun 2022 | - | -$27.27 M(+12.7%) | -$78.69 M(+17.4%) |
| Mar 2022 | - | -$24.19 M(+248.5%) | -$67.05 M(+14.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$58.74 M(+29.5%) | -$6.94 M(-65.8%) | -$58.74 M(-6.0%) |
| Sep 2021 | - | -$20.30 M(+29.9%) | -$62.48 M(+15.2%) |
| Jun 2021 | - | -$15.62 M(-1.7%) | -$54.22 M(+9.9%) |
| Mar 2021 | - | -$15.88 M(+48.8%) | -$49.35 M(+8.8%) |
| Dec 2020 | -$45.36 M(+267.7%) | -$10.68 M(-11.3%) | -$45.36 M(+21.2%) |
| Sep 2020 | - | -$12.04 M(+11.9%) | -$37.44 M(+29.3%) |
| Jun 2020 | - | -$10.76 M(-9.5%) | -$28.95 M(+37.6%) |
| Mar 2020 | - | -$11.89 M(+332.3%) | -$21.05 M(+70.6%) |
| Dec 2019 | -$12.34 M(+824.0%) | -$2.75 M(-22.5%) | -$12.34 M(+28.7%) |
| Sep 2019 | - | -$3.55 M(+24.4%) | -$9.59 M(+58.8%) |
| Jun 2019 | - | -$2.85 M(-10.4%) | -$6.04 M(+89.6%) |
| Mar 2019 | - | -$3.18 M | -$3.18 M |
| Dec 2018 | -$1.33 M | - | - |
FAQ
- What is Keros Therapeutics annual net profit?
- What is the all time high annual net income for Keros Therapeutics?
- What is Keros Therapeutics annual net income year-on-year change?
- What is Keros Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Keros Therapeutics?
- What is Keros Therapeutics quarterly net income year-on-year change?
- What is Keros Therapeutics TTM net profit?
- What is the all time high TTM net income for Keros Therapeutics?
- What is Keros Therapeutics TTM net income year-on-year change?
What is Keros Therapeutics annual net profit?
The current annual net income of KROS is -$187.35 M
What is the all time high annual net income for Keros Therapeutics?
Keros Therapeutics all-time high annual net profit is -$1.33 M
What is Keros Therapeutics annual net income year-on-year change?
Over the past year, KROS annual net profit has changed by -$34.36 M (-22.46%)
What is Keros Therapeutics quarterly net profit?
The current quarterly net income of KROS is -$46.03 M
What is the all time high quarterly net income for Keros Therapeutics?
Keros Therapeutics all-time high quarterly net profit is -$2.75 M
What is Keros Therapeutics quarterly net income year-on-year change?
Over the past year, KROS quarterly net profit has changed by $0.00 (0.00%)
What is Keros Therapeutics TTM net profit?
The current TTM net income of KROS is -$187.35 M
What is the all time high TTM net income for Keros Therapeutics?
Keros Therapeutics all-time high TTM net profit is -$3.18 M
What is Keros Therapeutics TTM net income year-on-year change?
Over the past year, KROS TTM net profit has changed by $0.00 (0.00%)